SOFIE is a molecular imaging company focused on empowering people with new PET technologies.
SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full line of imaging and radiochemistry systems and a premier radiopharmacy network and contract manufacturing organization to supply novel agents for diagnosis and therapy, the company is dedicated to improving patient health.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 5, 2018 | Grant | $5M | 1 | National Institutes of Health | — | Detail |
Oct 17, 2014 | Grant | $1.50M | 1 | — | — | Detail |
Oct 15, 2013 | Series A | $5M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
MRM Capital | — | Grant |